glp-1 ckd agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Potential renoprotective effects of GLP1
Description
This mini-review explores the role of gut peptides, particularly glucagonlike peptide-1 (GLP-1), in the improvement in glycemic control resulting from VSG and RYGB procedures
(2010, September 1)
WJPMR 2024
& Razvi, S
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Team R, RStudio
You may have seen Oprahs TV special about weight loss, or maybe you have a family member on one of these medications
